Revelation Biosciences, Inc.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-1/A Jul 21, 2022 AMENDMENT NO. 2 TO FORM S-1
S-1/A Jul 18, 2022 AMENDMENT NO. 1 TO FORM S-1
UPLOAD Jul 18, 2022
S-1 Jul 13, 2022 REGISTRATION STATEMENT
424B3 Jun 27, 2022 PROSPECTUS
EFFECT Jun 10, 2022
8-K Jun 10, 2022 8-K
CORRESP Jun 7, 2022
UPLOAD Jun 6, 2022
S-8 May 31, 2022 REGISTRATION STATEMENT
S-1 May 31, 2022 REGISTRATION STATEMENT
8-K May 31, 2022 8-K
8-K May 17, 2022 8-K
10-Q May 16, 2022 10-Q
8-K May 6, 2022 CURRENT REPORT
8-K/A Apr 22, 2022 AMENDMENT NO. 2 TO FORM 8-K
8-K/A Apr 15, 2022 AMENDMENT NO. 1 TO FORM 8-K
10-K Apr 15, 2022 ANNUAL REPORT
NT 10-K Mar 31, 2022 NOTIFICATION OF LATE FILING
SC 13G Mar 24, 2022 SC 13G
8-K Mar 15, 2022 CURRENT REPORT
SC 13G/A Mar 10, 2022 KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#2)
4 Feb 28, 2022 FORM 4 SUBMISSION
SC 13D Feb 15, 2022 SCHEDULE 13D
SC 13G/A Feb 14, 2022
← Newer Page 11 of 16 · 387 filings Older →